Sortase-conjugation generates a capsule vaccine that protects guinea pigs against Bacillus anthracis

Vaccine

Volumn 30, Issue 23, 2012, Pages 3435-3444

  Garufi, Gabriella ^a,b   Wang, Ya Ting ^a,b   Oh, So Young ^a,b   Maier, Hannah ^a,b   Missiakas, Dominique M ^a,b   Schneewind, Olaf ^a,b  

^a ARGONNE NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Anthrax; Anthrax vaccine adsorbed; Bacillus anthracis; Capsule vaccine; Domain 4; Poly d glutamic acid; Protective antigen; Sortase conjugation

Indexed keywords

ANTHRAX VACCINE; ANTIGEN; ANTIGEN PAGA; BACTERIAL VACCINE; GLUTAMIC ACID; POLY DEXTRO GAMMA GLUTAMIC ACID; POLY DEXTRO GAMMA GLUTAMIC ACID PLUS RECEPTOR BINDING DOMAIN; SORTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL VIRULENCE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHEMICAL BOND; CONTROLLED STUDY; EXPERIMENTAL GUINEA PIG; FEMALE; HISTOPATHOLOGY; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL CAPSULES; BACTERIAL TOXINS; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; GUINEA PIGS; MICE; MICE, INBRED C57BL; POLYGLUTAMIC ACID; SURVIVAL ANALYSIS; VACCINES, CONJUGATE;

EID: 84859823768     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.03.023     Document Type: Article

References (47)

1. Dochez A.R., Avery O.T. The elaboration of specific soluble substance by pneumococcus during growth. J Exp Med 1917, 26:477-493.
2. Heidelberger M., Goebel W.F., Avery O.T. The soluble specific substance of pneumococcus: third paper. J Exp Med 1925, 42:727-745.
3. Goebel W.F., Avery O.T. Chemo-immunological studies on conjugated carbohydrate-proteins. I. Synthesis of p-aminophenol β-glucoside, p-aminophenol β-galactoside, and their coupling with serum globulin. J Exp Med 1929, 50:521-531.
4. Avery O.T., Goebel W.F. Chemo-immunological studies on conjugated carbohydrate-protein. V. The immunological specificity of an antigen prepared by combining the capsular polysaccharide of type III pneumococcus with foreign protein. J Exp Med 1931, 54:437-447.
5. Robbins J.B., Schneerson R. Polysaccharide-protein conjugates: a new generation of vaccines. J Infect Dis 1990, 161:821-832.
6. Siber G.R. Pneumococcal disease: prospects for a new generation of vaccines. Science 1994, 265:1385-1387.
7. Robbins J.B., Schneerson R. Haemophilus influenzae type b: the search for a vaccine. Pediatr Infect Dis J 1987, 6:791-794.
8. Gotschlich E.C., Liu T.Y., Artenstein M.S. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med 1969, 129:1367-1384.
9. MacLeod C.M., Hodges R.G., Heidelberger M., Bernhard W.G. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J Exp Med 1945, 82:445-465.
10. Hermanson G.T. Bioconjugate techniques 2008, Academic Press, New York.
11. Schneewind O., Model P., Fischetti V.A. Sorting of protein A to the staphylococcal cell wall. Cell 1992, 70:267-281.
12. Ton-That H., Liu G., Mazmanian S.K., Faull K.F., Schneewind O. Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif. Proc Natl Acad Sci USA 1999, 96:12424-12429.
13. Koch R. Die Ätiologie der Milzbrand-Krankheit, begründet auf die Entwicklungsgeschichte des Bacillus anthracis. Beiträge zur Biologie der Pflanzen 1876, 2:277-310.
14. Preisz H. Experimentelle Studien über Virulenz, Empfänglichkeit und Immunität beim Milzbrand. Zeitschrift für Immunitäts-Forschung 1909, 5:341-452.
15. Bruckner V., Kovacs J., Denes G. Structure of poly-d-glutamic acid isolated from capsulated strains of B. anthracis. Nature 1953, 172:508.
16. Smith H., Keppie J., Stanley J.L. The chemical basis of the virulence of Bacillus anthracis. V. The specific toxin produced by Bacillus anthracis in vivo. Br J Exp Pathol 1955, 36:460-472.
17. Collier R.J., Young J.A. Anthrax toxin. Annu Rev Cell Dev Biol 2003, 19:45-70.
18. Bradley K.A., Mogridge J., Mourez M., Collier R.J., Young J.A. Identification of the cellular receptor for anthrax toxin. Nature 2001, 414:225-229.
19. Duesbery N.S., Webb C.P., Leppla S.H., Gordon V.M., Klimpel K.R., Copeland T.D., et al. Proteolytic inactivation of Map-kinase-kinase by anthrax lethal factor. Science 1998, 280:734-737.
20. Leppla S.H. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclin AMP concentrations in eukaryotic cells. Proc Natl Acad Sci USA 1982, 79:3162-3166.
21. Green B.D., Battisti L., Koehler T.M., Thorne C.B., Ivins B.E. Demonstration of a capsule plasmid in Bacillus anthracis. Infect Immun 1985, 49:291-297.
22. Ivins B.E., Ezzell J.W.J., Jemski J., Hedlund K.W., Ristroph J.D., Leppla S.H. Immunization studies with attenuated strains of Bacillus anthracis. Infect Immun 1986, 52:454-458.
23. Pasteur L. Le vaccin du charbon. Comptes Rendus Hebdomadaires des Scéances de l'Académie des Sciences 1881, 92:666-668.
24. Sterne M. Anthrax vaccines. J Am Vet Med Assoc 1988, 192:141.
25. Chabot D.J., Scorpio A., Tobery S.A., Little S.F., Norris S.L., Friedlander A.M. Anthrax capsule vaccine protects against experimental infection. Vaccine 2004, 23:43-47.
26. Schneerson R., Kubler-Kielb J., Liu T.Y., Dai Z.D., Leppla S.H., Yergey A., et al. Poly(gamma-d-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine. Proc Natl Acad Sci USA 2003, 100:8945-8950.
27. Wang T.T., Fellows P.F., Leighton T.J., Lucas A.H. Induction of opsonic antibodies to the gamma-d-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate. FEMS Immunol Med Microbiol 2004, 40:231-237.
28. Rhie G.E., Roehrl M.H., Mourez M., Collier R.J., Mekalanos J.J., Wang J.Y. A dually active anthrax vaccine that confers protection against both bacilli and toxins. Proc Natl Acad Sci USA 2003, 100:10925-10930.
29. Joyce J., Cook J., Chabot D., Hepler R., Shoop W., Xu Q., et al. Immunogenicity and protective efficacy of Bacillus anthracis poly-gamma-d-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy. J Biol Chem 2006, 281:4831-4843.
30. Kubler-Kielb J., Liu T.Y., Mocca C., Majadly F., Robbins J.B., Schneerson R. Additional conjugation methods and immunogenicity of Bacillus anthracis poly-gamma-d-glutamic acid-protein conjugates. Infect Immun 2006, 74:4744-4749.
31. Kim H.U., Goepfert J.M. A sporulation medium for Bacillus anthracis. J Appl Bacteriol 1974, 37(June):265-267.
32. Richter G.S., Anderson V.J., Garufi G., Lu L., Joachimiak A., He C., et al. Capsule anchoring in Bacillus anthracis occurs by a transpeptidation mechanism that is inhibited by capsidin. Mol Microbiol 2009, 71:404-420.
33. Gaspar A.H., Marraffini L.A., Glass E.M., DeBord K.L., Ton-That H., Schneewind O. Bacillus anthracis sortase A (SrtA) anchors LPXTG motif-containing surface proteins to the cell wall envelope. J Bacteriol 2005, 187:4646-4655.
34. Marraffini L.A., Schneewind O. Targeting proteins to the cell wall of sporulating Bacillus anthracis. Mol Microbiol 2006 Dec, 62:1402-1417.
35. Little S.F., Novak J.M., Lowe J.R., Leppla S.H., Singh Y., Klimpel K.R., et al. Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies. Microbiology 1996, 142:707-715.
36. Brossier F., Levy M., Landier A., Lafaye P., Mock M. Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies. Infect Immun 2004, 72:6313-6317.
37. Mazmanian S.K., Liu G., Ton-That H., Schneewind O. Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science 1999, 285:760-763.
38. Ivins B.E., Fellows P., Pitt L., Estep J., Farchaus J., Friedlander A.M., et al. Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine 1995, 18:1779-1784.
39. Grabenstein J.D. Vaccines: countering anthrax: vaccines and immunoglobulins. Clin Infect Dis 2008, 46:129-136.
40. Singer D.E., Schneerson R., Bautista C.T., Rubertone M.V., Robbins J.B., Taylor D.N. Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel. Vaccine 2008, 26:869-873.
41. Kern J.W., Schneewind O. BslA, a pXO1-encoded adhesin of Bacillus anthracis. Mol Microbiol 2008, 68:504-515.
42. Chand H.S., Drysdale M., Lovchik J., Koehler T.M., Lipscomb M.F., Lyons C.R. Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model. Infect Immun 2009, 77:429-435.
43. Marraffini L.A., DeDent A.C., Schneewind O. Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria. Microbiol Mol Biol Rev 2006, 70:192-221.
44. Schneewind O., Fowler A., Faull K.F. Structure of the cell wall anchor of surface proteins in Staphylococcus aureus. Science 1995, 268:103-106.
45. Bentley M.L., Lamb E.C., McCafferty D.G. Mutagenesis studies of substrate recognition and catalysis in the sortase A transpeptidase from Staphylococcus aureus. J Biol Chem 2008, 283:14762-14771.
46. Dumetz F., Jouvoin G., Khun H., Glomski I.J., Corre J.P., Rougeaux C., et al. Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax. Am J Pathol 2011, 178:2523-2535.
47. Drysdale M., Heninger S., Hutt J., Chen Y., Lyons C.R., Koehler T.M. Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. EMBO J 2005, 24:221-227.